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Background: Risk of coronary heart disease (CHD) is increased in HIV-infected patients. We examined the prognostic value of Apo B/A1 ratio, 
total/HDL cholesterol ratio and LDLp/HDLp ratio for CHD in HIV patients
Methods: Lipids, lipoproteins and particle concentrations were measured for 100 cases of CHD and 176 matched controls. Blood samples were 
obtained at baseline exam of the Strategies for Management of Anti-Retroviral Therapy (ART) (SMART) trial in which 5,472 HIV-infected patients with 
a CD4+ count > 350 cells/mm3 were randomized to intermittent or continuous ART. To compare the different lipids with one another, odds ratios 
(OR) for the 4th versus 1st quartile and for one standard deviation (SD) higher level are cited (SD and quartiles determined from cases and controls 
combined). ORs account for matching and were estimated using conditional logistic regression. ]2 statistics (twice the change in log-likelihood) 
were used to assess the predictive ability of each ratio.
Results:  Table1
ORs were similar after adjustment for other CHD risk factors. Taken individually, the strongest associations for the components of the ratio ranked by 
OR for the 4th versus 1st quartile were Apo B (OR=3.0; p=0.007), total cholesterol (2.9; 0.005), 1/total HDLp (2.6; 0.006), small LDLp (2.5; 0.014), 
1/HDLc (2.2; 0.017), and 1/Apo A1 (2.2; 0.026).
Conclusions:  Apo B/A1 ratio and the total/HDLc ratio are similarly predictive and more informative about risk of CHD than other individual lipid/
lipoprotein measures in HIV.
Table 1
Lipid Ratio
Median for Cases 
(IQR)
Median for Controls (IQR)
4th versus 1st 
Quartile
One SD Greater
OR (95% CI) X2(3df) OR (95% CI) X2 (1df)
Total chol/HDLc 6.0 (4.2-7.8) 4.6 (3.6-5.9) 4.9 (2.2-10.8) 22.0 1.7 (1.3-2.2) 15.8
ApoB/Apo A1 0.89 (0.68-1.08) 0.69 (0.57-0.85) 4.3 (1.9-9.5) 22.3 1.7 (1.3-2.3) 16.6
Small LDLp/Total HDLp 40.7 (23.5-58.3) 30.8 (19.3-44.8) 2.6 (1.3-5.4) 9.7 1.5 (1.2-2.0) 10.5
